All News

Top news of the day from across the health care landscape.

The FDA has granted Fast Track Designation for the development of PH94B (VistaGen Therapeutics), a neuroactive nasal spray for on-demand treatment of social anxiety disorder (SAD).

The FDA has approved the Unidose Liquid System (AptarGroup Inc) as the first and only nasal rescue treatment for acute repetitive seizures in patients with epilepsy.

The US Department of Health and Human Services (HHS) has entered an agreement with Sanofi Pasteur to increase the company's domestic pandemic influenza vaccine production capabilities.

Top news of the day from across the health care landscape.

Jesse C. Dresser, Esq explains how DIR fees affect specialty pharmacists at the NASP Annual Meeting in Washington, DC.

According to Janet Woodcock, MD and director of FDA’s Center for Drug Evaluation and Research, the agency is focused on the drugs used by Americans continuing to meet “strict quality standards.”

Officials with the FDA have approved Amgen’s infliximab-axxq (Avsola), a new biosimiliar to infliximab (Remicade).

The financial consequences of becoming disabled can be devastating if pharmacists lack proper financial planning.

Studying individuals’ genomes can help influence how different medications work for a patient, avoid harmful adverse drug reactions, and allow scientists to develop personalized medicines for patients with a wide range of diseases and disorders.

Top articles of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Fingolimod treats relapsing forms of multiple sclerosis in adult patients.

As more vaping cases are reported, patients may desire answers from their trusted providers.

A new method of targeted radiation therapy sends alpha-emitting particles directly to stroma cells in pancreatic cancer tissue.

The OTC Guide survey will be open for pharmacists to participate from Nov. 15, 2019, to March 1, 2020.

Top news of the day from across the health care landscape.

Men with breast cancer had higher mortality than women regardless of cancer type, treatment, and access to care.

Louisiana, Nevada, Texas rank highest in flu activity for the month of November.

Amneal has begun commercialization activities for the generic versions of sildenafil for oral suspension 10 mg/ml and aminocaproic acid tablets USP, 500 mg.

The approval for the first generic sucralfate oral suspension is 1 of the 15 complex products the manufacturer expects to launch over an 18- to 24-month period.